Sotera Health (SHC) Cash & Equivalents (2020 - 2026)

Sotera Health (SHC) has reported Cash & Equivalents for 7 consecutive years, with $314.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 3.21% year-over-year to $314.1 million; the TTM figure through Mar 2026 stood at $314.1 million (up 3.21% YoY), while the FY2025 annual figure was $344.6 million, up 24.3% from the prior year.
• Cash & Equivalents came in at $314.1 million for Q1 2026 at Sotera Health, down from $344.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $647.9 million in Q1 2023, with the low at $121.4 million in Q1 2022.
• Average Cash & Equivalents over 5 years is $291.7 million, with a median of $296.4 million recorded in 2023.
• Across the five-year window, Cash & Equivalents soared 433.55% in 2023 and slumped 59.7% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $395.2 million in 2022, then slipped by 25.0% to $296.4 million in 2023, then dropped by 6.47% to $277.2 million in 2024, then rose by 24.3% to $344.6 million in 2025, then dropped by 8.84% to $314.1 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $314.1 million, $344.6 million, and $299.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.